Middle East & Africa Live Biotherapeutic Products And Microbiome Cdmo Market Size & Outlook
Middle East & Africa live biotherapeutic products and microbiome cdmo market, 2018-2030 (US$M)
Related Markets
MEA live biotherapeutic products and microbiome cdmo market highlights
- The MEA live biotherapeutic products and microbiome cdmo market generated a revenue of USD 0.2 million in 2023.
- The market is expected to grow at a CAGR of 43.5% from 2024 to 2030.
- In terms of segment, c.difficle was the largest revenue generating application in 2023.
- C.difficle is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 0.2 million |
| Market revenue in 2030 | USD 2.2 million |
| Growth rate | 43.5% (CAGR from 2023 to 2030) |
| Largest segment | C.difficle |
| Fastest growing segment | C.difficle |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | C.difficle, Crohns disease, IBS, Diabetes |
| Key market players worldwide | Carbios SA, Boise Cascade Co, Assembly Biosciences Inc, Wacker Chemie AG, SGS AG, Lonza Group Ltd, Arranta Bio, 4D Pharma, NIZO, Inpac Pharma |
Other key industry trends
- In terms of revenue, MEA region accounted for 0.6% of the global live biotherapeutic products and microbiome cdmo market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 29.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Live Biotherapeutic Products And Microbiome CDMO Market Scope
Live Biotherapeutic Products And Microbiome CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa live biotherapeutic products and microbiome cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to live biotherapeutic products and microbiome cdmo market will help companies and investors design strategic landscapes.
C.difficle was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Middle East & Africa live biotherapeutic products and microbiome cdmo market based on c.difficle, crohns disease, ibs, diabetes covering the revenue growth of each sub-segment from 2018 to 2030.
In the Middle East & Africa, countries have developed healthcare infrastructure and biotechnology industry. The markets in this region are driven by the growing burden of IBD and Crohn’s disease, which has led to a need for various biotherapeutics.
The region has a high demand for outsourcing and R&D services, with a growing number of clinical trials. The growing population & rising government initiatives to improve access to healthcare and the presence of CDMOs are expected to encourage global biopharmaceutical & medical companies to enter the Middle East & Africa market.
For instance, in June 2023, Public Investment Fund, Saudi Arabia’s global investment organization, launched Lifera. It is a commercial-scale CDMO. This CDMO will enable the growth of the local biopharmaceutical industry and position the country/region as a destination for global pharmaceutical manufacturing.
Reasons to subscribe to Middle East & Africa live biotherapeutic products and microbiome cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa live biotherapeutic products and microbiome cdmo market databook
-
Our clientele includes a mix of live biotherapeutic products and microbiome cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa live biotherapeutic products and microbiome cdmo market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa live biotherapeutic products and microbiome cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA live biotherapeutic products and microbiome cdmo market size, by country, 2018-2030 (US$M)
Middle East & Africa Live Biotherapeutic Products And Microbiome CDMO Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
